Medicine
Uzedy 150 mg/0.42 mL extended-release injectable suspension
Uzedy 150 mg/0.42 mL extended-release injectable suspension is a prescription medicine containing Risperidone for subcutaneous use, marketed by Teva Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to…
Key facts
- Active ingredient (INN)
- Risperidone
- Brand
- Uzedy
- Strength
- 150 mg/0.42 mL
- Dosage form
- Extended-release injectable suspension
- Route
- Subcutaneous
- Packs
- 1 syringe of 0.42 mL
- Marketing authorisation holder
- Teva Pharmaceuticals
- Manufacturer
- Teva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store in refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. If unopened, UZEDY may be returned to refrigerated storage within 90 days. UZEDY may be stored in unopened original packaging at room temperature, 20°C to 25°C (68°F to 77°F), for up to 90 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AX08 Risperidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 May 2023
- Identifiers
- RxCUI 2636033, 2636039, 2636041 +7DailyMed set ID 734eb776-4be0-4808-834b-0d8b0f9e021eNDC 51759-740Application NDA213586
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / .42 mL in 1 syringe, glass | 51759-740-10 | Teva Pharmaceuticals | 1 May 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Risperidone
Clinical summary
Risperidone is an atypical antipsychotic indicated for treatment of schizophrenia, among other approved uses. It is available as tablets, orally disintegrating tablets and oral solution for subcutaneous use. MedsAcross supplies Risperidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RisperidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- RISPERDAL prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Okedi: European public assessment report (EPAR) · European Medicines Agency
Need Uzedy 150 mg/0.42 mL extended-release injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.